BAXTER INTERN 

€31.11
244
-€3.02-8.86% 今天

統計

當日最高
31.11
當日最低
31.11
52週最高
-
52週最低
-
成交量
2
平均成交量
-
市值
-
市盈率
-
股息收益率
3.41%
股息
1.06

即將到來

股息

3.41%股息收益率
10年增長
-3.73%
5年增長率
7.02%
3年增長率
5.19%
1年增長率
-1%

收益

24Oct確認
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.44
0.57
0.69
0.82
預期每股收益
0.7057927077
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 1BAX.MI 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Show more...
首席執行官
Mr. Jose E. Almeida
員工
60000
國家
US
ISIN
US0718131099
WKN
000853815

上市公司